Screener
Acadia Pharmaceuticals ACAD Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 160,252 | 133,507 | 331,271 | 259,877 |
| Total operating expenses | 270,123 | 232,192 | 542,801 | 457,219 |
| Income from operations | 37,836 | 32,374 | 33,220 | 51,663 |
| Interest income, net | 7,990 | 7,243 | 16,045 | 15,144 |
| Other income | 647 | 594 | 1,189 | 1,183 |
| Income before income taxes | 46,473 | 40,211 | 50,454 | 67,990 |
| Income tax expense | 14,973 | 13,545 | 15,317 | 22,337 |
| Net income | $31,500 | $26,666 | $35,137 | $45,653 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's interest expense?
- Acadia Pharmaceuticals (ACAD) reported interest expense of $7.99M in Q2 2026.
- How has Acadia Pharmaceuticals's interest expense changed year-over-year?
- Acadia Pharmaceuticals's interest expense increased by 10.3% year-over-year, from $7.24M to $7.99M.
- What is the long-term trend for Acadia Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's interest expense has grown at a 170.7% compound annual growth rate (CAGR), from $591K to $31.72M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Acadia Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude